Viewing StudyNCT00087009



Ignite Creation Date: 2024-05-05 @ 11:35 AM
Last Modification Date: 2024-10-26 @ 9:10 AM
Study NCT ID: NCT00087009
Status: TERMINATED
Last Update Posted: 2013-03-19
First Post: 2004-07-08

Brief Title: Beta-Glucan and Rituximab in Treating Young Patients With Relapsed or Progressive Lymphoma or Leukemia or Lymphoproliferative Disorder Related to Donor Stem Cell Transplantation
Sponsor:
Organization: Memorial Sloan Kettering Cancer Center